ɬÀï·¬

Journal News

Researchers get to the bottom of noninvasive gut tests

Mucus contains vital data to help address diseases such as inflammatory bowel disease and colon cancer
David Bidwell
By David Bidwell
March 3, 2024

New research from the University of British Columbia Okanagan, recently in the Journal of Biological Chemistry could make monitoring gut health easier and less painful by tapping into a common — yet often overlooked — source of information: the mucus in our digestive system that eventually becomes part of fecal matter.

Correct, what’s in our poop.

close-up of man holding his abdomen.
Liubomyr Vorona
New research from UBC Okanagan showed that noninvasive techniques can return vital gut health data from the mucus in our fecal matter.

Biology researcher Kirk Bergstrom and master’s student Noah Fancy found a noninvasive technique to study MUC2, a critical gut protein, from what we leave behind in the bathroom.

“MUC2 is like the silent star in our guts. It’s constantly working to protect us, and its proper functioning is crucial for our overall health,” Bergstrom said. “It was originally thought that you could only access this important molecule from biopsies or tissue removed via surgery — highly invasive and painful procedures.

“However, our study shows mucus is actually a part of our stool, meaning we can get at it painlessly and at levels we could not before. Anytime we can do analysis noninvasively, it’s a win.”

Clues to health can be found in unexpected places, and Bergstrom’s team found a way to study important gut health markers from fecal-adherent mucus — a term that, in simpler words, refers to the mucus attached to our stool. This mucus, typically ignored and flushed away, contains a trove of information about gut health.

MUC2, a glycoprotein with many sugar chains attached, forms a protective barrier in our intestines in the form of mucus, safeguarding our gut from harmful microbes and toxins and playing a crucial role in digestive health.

Understanding MUC2 better could lead to significant advancements in managing and preventing gut-related diseases, impacting the day-to-day well-being of millions.

“We can use these new methods to visualize mucus–microbiota interactions and how they go wrong in various diseases, like inflammatory bowel diseases and colon cancer,” Bergstrom noted.  “The sugars on the mucins also carry lots of information on the health status of the colon.”

Fancy led the work, which was the result of a strong collaborative effort between the Bergstrom Lab and the chemistry lab of Wesley Zandberg and the biology labs of Sepideh Pakpour, Deanna Gibson and Sanjoy Ghosh, all at UBC Okanagan.

This article was originally published in the . You can read the original.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
David Bidwell
David Bidwell

David Bidwell is a writer and content strategist, University Relations, University of British Columbia Okanagan.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Targeting toxins to treat whooping cough
Journal News

Targeting toxins to treat whooping cough

May 1, 2025

Scientists find that liver protein inhibits of pertussis toxin, offering a potential new treatment for bacterial respiratory disease. Read more about this recent study from the Journal of Biological Chemistry.

Elusive zebrafish enzyme in lipid secretion
Journal News

Elusive zebrafish enzyme in lipid secretion

May 1, 2025

Scientists discover that triacylglycerol synthesis enzyme drives lipoproteins secretion rather than lipid droplet storage. Read more about this recent study from the Journal of Biological Chemistry.

Scientists identify pan-cancer biomarkers
Journal News

Scientists identify pan-cancer biomarkers

April 30, 2025

Researchers analyze protein and RNA data across 13 cancer types to find similarities that could improve cancer staging, prognosis and treatment strategies. Read about this recent article published in Molecular & Cellular Proteomics.

New mass spectrometry tool accurately identifies bacteria
Journal News

New mass spectrometry tool accurately identifies bacteria

April 30, 2025

Scientists develop a software tool to categorize microbe species and antibiotic resistance markers to aid clinical and environmental research. Read about this recent article published in Molecular & Cellular Proteomics.

New tool matches microbial and metabolic metaproteomic data
Journal News

New tool matches microbial and metabolic metaproteomic data

April 30, 2025

Scientists develop a bioinformatics program that maps omics data to metabolic pathways. Read about this recent article published in Molecular & Cellular Proteomics

Meet Paul Shapiro
Interview

Meet Paul Shapiro

April 29, 2025

Learn how the JBC associate editor went from milking cows on a dairy farm to analyzing kinases in the lab.